Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-7-15
pubmed:abstractText
This study compared the antitumor activity and the pharmacological profile of gimatecan given orally and irinotecan (CPT-11) on pediatric tumor xenografts.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1432-0843
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
635-41
pubmed:meshHeading
pubmed-meshheading:20091168-Administration, Oral, pubmed-meshheading:20091168-Animals, pubmed-meshheading:20091168-Antineoplastic Agents, Phytogenic, pubmed-meshheading:20091168-Area Under Curve, pubmed-meshheading:20091168-Camptothecin, pubmed-meshheading:20091168-Cell Line, Tumor, pubmed-meshheading:20091168-Cell Proliferation, pubmed-meshheading:20091168-Child, pubmed-meshheading:20091168-Chromatography, High Pressure Liquid, pubmed-meshheading:20091168-Half-Life, pubmed-meshheading:20091168-Humans, pubmed-meshheading:20091168-Male, pubmed-meshheading:20091168-Mice, pubmed-meshheading:20091168-Mice, Nude, pubmed-meshheading:20091168-Neuroblastoma, pubmed-meshheading:20091168-Rhabdomyosarcoma, pubmed-meshheading:20091168-Tetrazolium Salts, pubmed-meshheading:20091168-Thiazoles, pubmed-meshheading:20091168-Xenograft Model Antitumor Assays
pubmed:year
2010
pubmed:articleTitle
Antitumor activity and pharmacokinetics of oral gimatecan on pediatric cancer xenografts.
pubmed:affiliation
Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, Milan, Italy. zucchetti@marionegri.it
pubmed:publicationType
Journal Article